Skip to main content
Top
Published in: BMC Public Health 2/2011

Open Access 01-12-2011 | Review

Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments

Authors: Mark M Fukuda, Terry A Klein, Tadeusz Kochel, Talia M Quandelacy, Bryan L Smith, Jeff Villinski, Delia Bethell, Stuart Tyner, Youry Se, Chanthap Lon, David Saunders, Jacob Johnson, Eric Wagar, Douglas Walsh, Matthew Kasper, Jose L Sanchez, Clara J Witt, Qin Cheng, Norman Waters, Sanjaya K Shrestha, Julie A Pavlin, Andres G Lescano, Paul CF Graf, Jason H Richardson, Salomon Durand, William O Rogers, David L Blazes, Kevin L Russell, the AFHSC-GEIS Malaria and Vector Borne Infections Writing Group

Published in: BMC Public Health | Special Issue 2/2011

Login to get access

Abstract

Vector-borne infections (VBI) are defined as infectious diseases transmitted by the bite or mechanical transfer of arthropod vectors. They constitute a significant proportion of the global infectious disease burden. United States (U.S.) Department of Defense (DoD) personnel are especially vulnerable to VBIs due to occupational contact with arthropod vectors, immunological naiveté to previously unencountered pathogens, and limited diagnostic and treatment options available in the austere and unstable environments sometimes associated with military operations. In addition to the risk uniquely encountered by military populations, other factors have driven the worldwide emergence of VBIs. Unprecedented levels of global travel, tourism and trade, and blurred lines of demarcation between zoonotic VBI reservoirs and human populations increase vector exposure. Urban growth in previously undeveloped regions and perturbations in global weather patterns also contribute to the rise of VBIs. The Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) and its partners at DoD overseas laboratories form a network to better characterize the nature, emergence and growth of VBIs globally. In 2009 the network tested 19,730 specimens from 25 sites for Plasmodium species and malaria drug resistance phenotypes and nearly another 10,000 samples to determine the etiologies of non-Plasmodium species VBIs from regions spanning from Oceania to Africa, South America, and northeast, south and Southeast Asia. This review describes recent VBI-related epidemiological studies conducted by AFHSC-GEIS partner laboratories within the OCONUS DoD laboratory network emphasizing their impact on human populations.
Literature
1.
go back to reference Morens DM, Folkers GK, Fauci AS: The challenge of emerging and re-emerging infectious diseases. Nature. 2004, 430 (6996): 242-9. 10.1038/nature02759.CrossRefPubMed Morens DM, Folkers GK, Fauci AS: The challenge of emerging and re-emerging infectious diseases. Nature. 2004, 430 (6996): 242-9. 10.1038/nature02759.CrossRefPubMed
2.
go back to reference Russell P: Communicable Diseases: Malaria. Edited by: C. JB. 1963, Washington DC: Office of the Surgeon General, Department of the Army, VI: Russell P: Communicable Diseases: Malaria. Edited by: C. JB. 1963, Washington DC: Office of the Surgeon General, Department of the Army, VI:
3.
go back to reference Malaria acquired in Haiti - 2010. MMWR Morb Mortal Wkly Rep. 59 (8): 217-9. Malaria acquired in Haiti - 2010. MMWR Morb Mortal Wkly Rep. 59 (8): 217-9.
4.
go back to reference Witt C: The AFHSC/Division of GEIS Operations Predictive Surveillance Program: A Multidisciplinary Approach for the Early Detection and Response to Disease Outbreaks. 2010 Witt C: The AFHSC/Division of GEIS Operations Predictive Surveillance Program: A Multidisciplinary Approach for the Early Detection and Response to Disease Outbreaks. 2010
5.
go back to reference Vijaykadga S, et al: In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health. 2006, 11 (2): 211-9. 10.1111/j.1365-3156.2005.01557.x.CrossRefPubMed Vijaykadga S, et al: In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health. 2006, 11 (2): 211-9. 10.1111/j.1365-3156.2005.01557.x.CrossRefPubMed
6.
go back to reference Denis MB, et al: Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health. 2006, 11 (12): 1800-7. 10.1111/j.1365-3156.2006.01739.x.CrossRefPubMed Denis MB, et al: Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health. 2006, 11 (12): 1800-7. 10.1111/j.1365-3156.2006.01739.x.CrossRefPubMed
7.
go back to reference Noedl H, et al: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359 (24): 2619-20. 10.1056/NEJMc0805011.CrossRefPubMed Noedl H, et al: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359 (24): 2619-20. 10.1056/NEJMc0805011.CrossRefPubMed
8.
go back to reference Bethell D, S Y, Lon C, Socheat D, Saunders S, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, S S, Kuntawungin W, Surasri S, Lee S, Sarim S, Tyner S, Smith B, Fukuda M: Dose-Dependant Risk of Neutropenia Following 7-day Courses of Artesunate Monotherapy in Cambodian Patients with Acute P. falciparum Malaria. Clinical Infectious Diseases. 2010 Bethell D, S Y, Lon C, Socheat D, Saunders S, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, S S, Kuntawungin W, Surasri S, Lee S, Sarim S, Tyner S, Smith B, Fukuda M: Dose-Dependant Risk of Neutropenia Following 7-day Courses of Artesunate Monotherapy in Cambodian Patients with Acute P. falciparum Malaria. Clinical Infectious Diseases. 2010
9.
go back to reference Rogers WO, et al: Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009, 8: 10-10.1186/1475-2875-8-10.PubMedCentralCrossRefPubMed Rogers WO, et al: Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009, 8: 10-10.1186/1475-2875-8-10.PubMedCentralCrossRefPubMed
10.
go back to reference Dondorp AM, et al: Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 8 (4): 272-80. Dondorp AM, et al: Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 8 (4): 272-80.
11.
go back to reference Wootton JC, et al: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002, 418 (6895): 320-3. 10.1038/nature00813.CrossRefPubMed Wootton JC, et al: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002, 418 (6895): 320-3. 10.1038/nature00813.CrossRefPubMed
12.
go back to reference Roper C, et al: Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004, 305 (5687): 1124-10.1126/science.1098876.CrossRefPubMed Roper C, et al: Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004, 305 (5687): 1124-10.1126/science.1098876.CrossRefPubMed
13.
go back to reference Amin AA, et al: The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007, 6: 72-10.1186/1475-2875-6-72.PubMedCentralCrossRefPubMed Amin AA, et al: The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007, 6: 72-10.1186/1475-2875-6-72.PubMedCentralCrossRefPubMed
14.
go back to reference Durand S, Cabezas C, Alvares Antonio C, Galves Montoya M, Montalvan C, McCollum A, Soberon V, Udhayakumar V, Lucas C, Graf P, Bacon D: Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru. American Society of Tropical Medicine and Hygiene 58th Annual Meeting. 2009, American Society of Tropical Medicine and Hygiene: Washington DC Durand S, Cabezas C, Alvares Antonio C, Galves Montoya M, Montalvan C, McCollum A, Soberon V, Udhayakumar V, Lucas C, Graf P, Bacon D: Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru. American Society of Tropical Medicine and Hygiene 58th Annual Meeting. 2009, American Society of Tropical Medicine and Hygiene: Washington DC
15.
go back to reference Durand S, Santolalla M, Salas C, Soberon V, Alvares Antonio C, Montalvan C, Galves Montoya M, McCollum A, Green M, Lucas C, Udhayakumar V, Graf P, Bacon D: A Probable Case of Chloroquine-resistant Plasmodium vivax in the Peruvian Amazon. American Society of Tropical Medicine and Hygiene 58th Annual Meeting. 2009, American Society of Tropical Medicine and Hygiene: Washington DC Durand S, Santolalla M, Salas C, Soberon V, Alvares Antonio C, Montalvan C, Galves Montoya M, McCollum A, Green M, Lucas C, Udhayakumar V, Graf P, Bacon D: A Probable Case of Chloroquine-resistant Plasmodium vivax in the Peruvian Amazon. American Society of Tropical Medicine and Hygiene 58th Annual Meeting. 2009, American Society of Tropical Medicine and Hygiene: Washington DC
16.
go back to reference Lee SW, et al: Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea. Am J Trop Med Hyg. 2009, 81 (4): 600-4. 10.4269/ajtmh.2009.09-0102.CrossRefPubMed Lee SW, et al: Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea. Am J Trop Med Hyg. 2009, 81 (4): 600-4. 10.4269/ajtmh.2009.09-0102.CrossRefPubMed
17.
go back to reference Freedman DO, et al: Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006, 354 (2): 119-30. 10.1056/NEJMoa051331.CrossRefPubMed Freedman DO, et al: Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006, 354 (2): 119-30. 10.1056/NEJMoa051331.CrossRefPubMed
19.
go back to reference Doherty JF, Grant AD, Bryceson AD: Fever as the presenting complaint of travellers returning from the tropics. Qjm. 1995, 88 (4): 277-81.PubMed Doherty JF, Grant AD, Bryceson AD: Fever as the presenting complaint of travellers returning from the tropics. Qjm. 1995, 88 (4): 277-81.PubMed
20.
go back to reference Aguilar PV, et al: Guaroa virus infection among humans in Bolivia and Peru. Am J Trop Med Hyg. 83 (3): 714-21. Aguilar PV, et al: Guaroa virus infection among humans in Bolivia and Peru. Am J Trop Med Hyg. 83 (3): 714-21.
21.
go back to reference Pandey BD, et al: First case of Dengue virus infection in Nepal. Nepal Med Coll J. 2004, 6 (2): 157-9.PubMed Pandey BD, et al: First case of Dengue virus infection in Nepal. Nepal Med Coll J. 2004, 6 (2): 157-9.PubMed
23.
go back to reference Schmidt AC: Response to dengue fever--the good, the bad, and the ugly?. N Engl J Med. 363 (5): 484-7. 10.1056/NEJMcibr1005904. Schmidt AC: Response to dengue fever--the good, the bad, and the ugly?. N Engl J Med. 363 (5): 484-7. 10.1056/NEJMcibr1005904.
24.
go back to reference Addressing Emerging Infectious Disease Threats: A Strategic Plan for the Department of Defense. 1998, Walter Reed Army Institute of Research: Washington DC Addressing Emerging Infectious Disease Threats: A Strategic Plan for the Department of Defense. 1998, Walter Reed Army Institute of Research: Washington DC
25.
go back to reference Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. Workshop Summary. Forum on Microbial Threats. 2008, Institute of Medicine of the National Academies: Washington, DC Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. Workshop Summary. Forum on Microbial Threats. 2008, Institute of Medicine of the National Academies: Washington, DC
26.
go back to reference Jones KE, et al: Global trends in emerging infectious diseases. Nature. 2008, 451 (7181): 990-3. 10.1038/nature06536.CrossRefPubMed Jones KE, et al: Global trends in emerging infectious diseases. Nature. 2008, 451 (7181): 990-3. 10.1038/nature06536.CrossRefPubMed
28.
go back to reference Song JW, et al: Characterization of Imjin virus, a newly isolated hantavirus from the Ussuri white-toothed shrew (Crocidura lasiura). J Virol. 2009, 83 (12): 6184-91. 10.1128/JVI.00371-09.PubMedCentralCrossRefPubMed Song JW, et al: Characterization of Imjin virus, a newly isolated hantavirus from the Ussuri white-toothed shrew (Crocidura lasiura). J Virol. 2009, 83 (12): 6184-91. 10.1128/JVI.00371-09.PubMedCentralCrossRefPubMed
29.
go back to reference Baek LJ, et al: Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea. J Med Virol. 2006, 78 (2): 290-7. 10.1002/jmv.20538.CrossRefPubMed Baek LJ, et al: Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea. J Med Virol. 2006, 78 (2): 290-7. 10.1002/jmv.20538.CrossRefPubMed
30.
go back to reference Song KJ, et al: Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J Gen Virol. 2007, 88 (Pt 11): 3121-9. 10.1099/vir.0.83139-0.PubMedCentralCrossRefPubMed Song KJ, et al: Muju virus, a novel hantavirus harboured by the arvicolid rodent Myodes regulus in Korea. J Gen Virol. 2007, 88 (Pt 11): 3121-9. 10.1099/vir.0.83139-0.PubMedCentralCrossRefPubMed
31.
go back to reference Burnette WN, et al: Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. Mil Med. 2008, 173 (2): 174-81.CrossRefPubMed Burnette WN, et al: Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military. Mil Med. 2008, 173 (2): 174-81.CrossRefPubMed
32.
go back to reference Integrated Capabilities Development Team: "Infectious Disease Threats to the US Military Prioritization Panel Results". 2010, Memorandum for Record, Fort Sam Houston, TX Integrated Capabilities Development Team: "Infectious Disease Threats to the US Military Prioritization Panel Results". 2010, Memorandum for Record, Fort Sam Houston, TX
33.
go back to reference Gu W, et al: Fundamental issues in mosquito surveillance for arboviral transmission. Trans R Soc Trop Med Hyg. 2008, 102 (8): 817-22. 10.1016/j.trstmh.2008.03.019.PubMedCentralCrossRefPubMed Gu W, et al: Fundamental issues in mosquito surveillance for arboviral transmission. Trans R Soc Trop Med Hyg. 2008, 102 (8): 817-22. 10.1016/j.trstmh.2008.03.019.PubMedCentralCrossRefPubMed
34.
go back to reference Eisen L, et al: ProactiveVector control strategies and improved monitoring and evaluation practices for dengue prevention. J Med Entomol. 2009, 46 (6): 1245-55. 10.1603/033.046.0601.CrossRefPubMed Eisen L, et al: ProactiveVector control strategies and improved monitoring and evaluation practices for dengue prevention. J Med Entomol. 2009, 46 (6): 1245-55. 10.1603/033.046.0601.CrossRefPubMed
Metadata
Title
Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments
Authors
Mark M Fukuda
Terry A Klein
Tadeusz Kochel
Talia M Quandelacy
Bryan L Smith
Jeff Villinski
Delia Bethell
Stuart Tyner
Youry Se
Chanthap Lon
David Saunders
Jacob Johnson
Eric Wagar
Douglas Walsh
Matthew Kasper
Jose L Sanchez
Clara J Witt
Qin Cheng
Norman Waters
Sanjaya K Shrestha
Julie A Pavlin
Andres G Lescano
Paul CF Graf
Jason H Richardson
Salomon Durand
William O Rogers
David L Blazes
Kevin L Russell
the AFHSC-GEIS Malaria and Vector Borne Infections Writing Group
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue Special Issue 2/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-S2-S9

Other articles of this Special Issue 2/2011

BMC Public Health 2/2011 Go to the issue